Potent P2Y12 Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI
Caio A.M. Tavares, Patrícia O. Guimarães, Marcelo Franken, José Mariani, Stefano G.D. Lemos, Breno Oliveira Almeida, Eduardo B. Martins, Estêvão Lanna Figueiredo, A ROCHA, Alexandre Soares, Marcos Maynar-Mariño, Bruno Paolino, Mayler Olombrada Nunes de Santos, Paulo Caramori, Rodrigo M Joaquim, Edgar Freitas Quintella, André F.de P. Antonangelo, A. Fonseca, Marcos S. Silveira, Marta Fonseca, Frederico Monfardini, Silvia R.L. Assis, L. Costa, José Carlos Nicolau, Andrei C. Spósito, Renato D. Lopes, Yoshinobu Onuma, Marco Valgimigli, Dominick J. Angiolillo, Patrick W. Serruys, Otávio Berwanger, Raúl D. Santos, Fernando Bacal, Pedro A. Lemos (2025). Potent P2Y12 Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI. , DOI: https://doi.org/10.1016/j.jacc.2025.10.058.
